- Myeloproliferative neoplasm with basophilia and abnormality of platelet-derived growth factor receptor a translocation: a case report
-
Choi JG, Cho DY
- KMID: 2527499
- Blood Res.
- 2022 Mar;57(1):69-74.
- doi: 10.5045/br.2022.2021138
-
- CITED
-
- Close
- SHARE
-
- Close
- Dasatinib-induced reversible pulmonary arterial hypertension in a pediatric patient with BCR/ABL1+ lymphoblastic lymphoma from chronic myeloid leukemia
-
Han Hj, Hong KT, Choi JY, Lee SY, Kang HJ
- KMID: 2527502
- Blood Res.
- 2022 Mar;57(1):80-84.
- doi: 10.5045/br.2021.2021198
-
- CITED
-
- Close
- SHARE
-
- Close
- COVID-19 pneumonia concurrent with newly diagnosed chronic myelogenous leukemia
-
Kim CS, Kim JY, Choi DR
- KMID: 2527500
- Blood Res.
- 2022 Mar;57(1):74-75.
- doi: 10.5045/br.2022.2021146
-
- CITED
-
- Close
- SHARE
-
- Close
- Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second
-
Kim JH, Park SS, Yoon JH, Lee SE, Kim HJ, Min CK
- KMID: 2527501
- Blood Res.
- 2022 Mar;57(1):76-80.
- doi: 10.5045/br.2022.2021183
-
- CITED
-
- Close
- SHARE
-
- Close
- Appearances are deceiving: immature lymphocytes in Leishmaniasis
-
Galiacho VR, Pomposo MP, Echebarria-Barona A, Urdiales PG, García Ruiz JC
- KMID: 2527489
- Blood Res.
- 2022 Mar;57(1):4-4.
- doi: 10.5045/br.2022.2021191
-
- CITED
-
- Close
- SHARE
-
- Close
- ALK-positive anaplastic large cell lymphoma that presented as pleural effusion
-
Kim DH, Sun X
- KMID: 2527490
- Blood Res.
- 2022 Mar;57(1):5-5.
- doi: 10.5045/br.2022.2021207
-
- CITED
-
- Close
- SHARE
-
- Close
- A call for vigilance: thrombotic thrombocytopenic syndrome caused by mRNA COVID-19 vaccine associated with muscle weakness
-
Kim CS, Kwak JG, Jang S, Bang SM
- KMID: 2527488
- Blood Res.
- 2022 Mar;57(1):1-3.
- doi: 10.5045/br.2022.2021134
-
- CITED
-
- Close
- SHARE
-
- Close
- IDH1/2 mutations in acute myeloid leukemia
-
Byun JM, Yoo SJ, Kim HJ, Ahn JS, Koh Y, Jang JH, Yoon SS
- KMID: 2527492
- Blood Res.
- 2022 Mar;57(1):13-19.
- doi: 10.5045/br.2021.2021152
The mutational and epigenetic landscape of acute myeloid leukemia (AML) has become increasingly well understood in recent years, informing on biological targets for precision medicine. Among the most notable findings... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of immune thrombocytopenia: 2022 update of Korean experts recommendations
-
Park YH, Kim DY, Kim S, Choi YB, Shin DY, Kim JS, Lee WS, Mun YC, Jang JH, Lee JW, Kook H, on behalf of Korean Aplastic Anemia Working Party
- KMID: 2527493
- Blood Res.
- 2022 Mar;57(1):20-28.
- doi: 10.5045/br.2022.2022043
Despite the availability of therapies to treat patients with immune thrombocytopenia (ITP), there is currently little data from randomized trials to assist clinicians in managing patients. The evidence-based guidelines of... -
- CITED
-
- Close
- SHARE
-
- Close
- Convalescent plasma in COVID-19: renewed focus on the timing and effectiveness of an old therapy
-
Nashaat HAH, Anani M, Attia FM
- KMID: 2527491
- Blood Res.
- 2022 Mar;57(1):6-12.
- doi: 10.5045/br.2021.2021151
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic that has strained health care systems worldwide and resulted in high mortality. The current... -
- CITED
-
- Close
- SHARE
-
- Close
- Prophylaxis for invasive fungal infection in pediatric patients with allogeneic hematopoietic stem cell transplantation
-
Perez P, Patiño J, Franco AA, Rosso F, Beltran E, Manzi E, Castro A, Estacio M, Valencia DM
- KMID: 2527495
- Blood Res.
- 2022 Mar;57(1):34-40.
- doi: 10.5045/br.2021.2021127
Background Antifungal prophylaxis is recommended for hematopoietic stem cell transplantation (HSCT) to decrease the incidence of invasive fungal infections (IFI). This study aimed to compare the two groups of antifungal prophylaxis... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen
-
Kim SI, Jung SH, Yhim HY, Jo JC, Song GY, Kim M, Ahn SY, Ahn JS, Yang DH, Kim HJ, Lee JJ
- KMID: 2527497
- Blood Res.
- 2022 Mar;57(1):51-58.
- doi: 10.5045/br.2021.2021176
Background Although survival outcomes of multiple myeloma (MM) have improved with the development of new and effective agents, infection remains the major cause of morbidity and mortality. Here, we evaluated the... -
- CITED
-
- Close
- SHARE
-
- Close
- Induction-related mortality in adolescents and young adults with acute lymphoblastic leukemia in a resource-limited setting: do treatment-related complications create more impact than disease biology?
-
Inclan-Alarcon SI, Riviello-Goya S, Teran-De-la-Sancha K, Fierro-Angulo OM, Acosta-Medina AA, Demichelis-Gomez R, Bourlon C
- KMID: 2527494
- Blood Res.
- 2022 Mar;57(1):29-33.
- doi: 10.5045/br.2021.2021058
Background Acute lymphoblastic leukemia (ALL) is a malignant clonal bone marrow disorder with a high mortality rate during the initial therapy. This retrospective study aimed to describe and analyze the risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Myelofibrotic and leukemic transformation in 2016 WHO-defined Philadelphia-negative myeloproliferative neoplasm
-
Song IC, Yeon SH, Lee MW, Ryu H, Lee HJ, Yun HJ, Kim SY, Jo DY
- KMID: 2527498
- Blood Res.
- 2022 Mar;57(1):59-68.
- doi: 10.5045/br.2021.2021209
Background Information on myelofibrotic and leukemic transformations in Korean Philadelphia chromosome-negative myeloproliferative neoplasms (Ph ‒ MPNs) is limited. Methods This study retrospectively analyzed transformations in patients diagnosed with essential thrombocythemia (ET), polycythemia vera... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical characteristics and treatment outcomes of children and adolescents with aggressive mature B-cell lymphoma: a single-center analysis
-
Jeon W, Koh YK, Kang S, Kim H, Koh KN, Im HJ
- KMID: 2527496
- Blood Res.
- 2022 Mar;57(1):41-50.
- doi: 10.5045/br.2021.2021164
Background Aggressive mature B-cell non-Hodgkin lymphoma (B-NHL) is the most common non-Hodgkin lymphoma in children. The outcome of chemotherapy for B-NHL has improved over decades. Methods We reviewed 82 children and adolescents with... -
- CITED
-
- Close
- SHARE
-
- Close
